Paysign PAYS Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Other Revenue | $610.36K+9.3% | $558.37K-31.5% | $815.4K+40.5% | $580.52K+1.9% | $569.62K+15.4% | |
| Pharma Industry | $15.68M+63.4% | $9.6M+21.1% | $7.92M+2.1% | $7.75M-10.0% | $8.62M+99.8% | |
| Plasma Industry | $11.75M-6.8% | $12.6M-2.0% | $12.86M+19.7% | $10.74M+14.2% | $9.41M-12.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Paysign break its business down?
- Paysign (PAYS) reports revenue by product across 3 parts — Other Revenue, Pharma Industry and Plasma Industry. Each is extracted from the segment footnotes and tracked over time.
- Where does Paysign's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Paysign's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
